I don’t currently have live access to up-to-the-minute news feeds in this chat, but I can summarize the most recent publicly known developments around Nicotiana tabacum up to late 2023–2024 and point you to where you can verify newer items.
What Nicotiana tabacum is known for lately
- Biofactory research: Tobacco plants are used as platforms for producing pharmaceuticals and high-value compounds via new breeding techniques (NBTs). Projects like NEWCOTIANA explored turning tobacco leaves into biofactories for vaccines, antibodies, and nutraceuticals, aiming to diversify income for tobacco-growing regions [ISAAA, 2018; CORDIS, 2018]. If you’re tracking current status, look for follow-up results or product demonstrations from ongoing NPBT projects or EU-funded initiatives in 2019–2024.[1][2]
- Genome sequencing and diversity: There has been continuing progress in sequencing and assembling the tobacco genome, including work on N. tabacum cultivars used for flue-cured tobacco and cigars, which supports functional genomics and trait breeding [Frontiers in Plant Science, 2024; Frontiers 2024 update; 2025–2026 genome reports]. For the latest cultivars and assemblies, check recent plant genomics journals or genome announce databases.[3][9]
- Nicotine biosynthesis and regulation: Research continues to identify genes controlling nicotine synthesis, enabling more precise metabolic engineering to alter nicotine content or composition in different tissues, which has implications for crop value and product safety [Journal of Experimental Botany, 2024; related reviews]. Updated reviews or primary studies in 2023–2025 would have the newest gene targets and regulatory networks.[7]
- EU agricultural and biosafety context: In Europe, tobacco breeding programs have sought to reposition N. tabacum from traditional smoking products toward multipurpose uses, with attention to biosafety, regulatory compliance, and public engagement as NPBTs mature [CORDIS and related EU project pages].[2]
Where to look for the latest news
- Major plant science and biotechnology journals: Frontiers in Plant Science, Journal of Experimental Botany, Plant Biotechnology Journal for genome, regulatory, and bioproduct developments involving Nicotiana tabacum.[3][7]
- EU research portals and project pages: CORDIS and ISAAA updates often provide timely summaries ofMid- to late-stage NPBT projects and tobacco as a biofactory.[1][2]
- General science news outlets and trade press: ScienceNews, Nature Biotechnology, and agricultural policy outlets frequently report on tobacco’s role in plant biotechnology and biofactory applications.
If you’d like, I can look up the very latest articles and assemble a concise, cited briefing with a short timeline and key figures. I can also extract and summarize specific topics (e.g., latest genome assemblies, NPBT applications, or regulatory news) if you specify your preferred focus.
Sources
This datasheet on Nicotiana tabacum covers Identity, Overview, Associated Diseases, Pests or Pathogens, Distribution, Dispersal, Hosts/Species Affected, Biology & Ecology, Environmental Requirements, Natural Enemies, Impacts, Uses, Management, Economics, ...
www.cabidigitallibrary.orgInvestigating plant genomes offers crucial foundational resources for exploring various aspects of plant biology and applications, such as functional genomic...
www.frontiersin.orgMolecular and genomics studies have revealed metabolic and regulatory genes involved in nicotine biosynthesis, enabling us to develop tobacco plants with u
academic.oup.comCRISPR/Cas9 genome editing for gene inactivation was successfully implemented in *N. tabacum* BY-2 suspension cells. Transformation was carried out in a transgenic line that expressed a red fluorescent protein (mCherry) with a binary vector with the Cas9 coding genes and three guide RNAs targeted to mCherry restriction sites, besides containing a selection gene bialaphos-resistant (bar). … *N. glauca* and anabasine-rich extracts have been shown to be teratogenic in goats when administered on...
www.sciencedirect.comResearchers at the Molecular and Cellular Plant Biology Institute (IBMCP) of the Universitat Politècnica de València in Spain, along with the Spanish National Research Council (CSIC), are collaborating for the NEWCOTIANA project, a research and innovation initiative, which makes use of new plant breeding technologies to produce medicine, cosmetics, and other products of added value in tobacco plants.
www.isaaa.orgNicotiana tabacum is an allotetraploid hybrid of Nicotiana sylvestris and Nicotiana tomentosiformis and a model organism in genetics. However, features of subgenome evolution, expression coordination, genetic diversity and complex traits regulation ...
pmc.ncbi.nlm.nih.govThe Biodiversity Heritage Library works collaboratively to make biodiversity literature openly available to the world as part of a global biodiversity community.
www.biodiversitylibrary.orgA group of New Plant Breeding Techniques (NPBT) has opened unprecedented opportunities in agriculture. Those NPBTs are at least as efficient and often more precise than previous traditional and GM techniques, while circumventing the introduction of heritable transgenes from...
cordis.europa.eu